These findings support our hypothesis that RRTFB‐derived flavonoids attenuate DNMT3a‐mediated SIRT1 promoter methylation, thereby restoring its anti‐adipogenic and anti‐inflammatory functions in obesity. Here, DNMT3A is linked to obesity disorder.